Skip to main content
An official website of the United States government

Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Staff List

Photo Name, Email, Phone Room Group(s)/Office
Asefa, Wosene
wosene.asefa@nih.gov
240-276-6422
5E504 Program Support Assistant | Chemopreventive Agent Development
Biswas, Kajal, Ph.D.
kajal.biswas2@nih.gov
240-276-5614
5E540 Program Officer | Chemopreventive Agent Development
Cholewa, Brian, Ph.D.
brian.cholewa@nih.gov
240-276-7545
5E446 Deputy Chief | Chemopreventive Agent Development
Clifford, John, Ph.D.
john.clifford@nih.gov
202-235-4482
5E430 Program Officer | Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D.
vignesh.gunasekharan@nih.gov
240-276-5814
5E438 Program Officer | Chemopreventive Agent Development
Mohammed, Altaf, Ph.D.
altaf.mohammed@nih.gov
240-276-6082
5E542 Deputy Chief | Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S.
ancy.nalli@nih.gov
202-276-5265
5E536 Program Officer | Chemopreventive Agent Development
Sei, Shizuko, M.D.
shizuko.sei@nih.gov
240-276-5005
5E452 Co-Chief | Chemopreventive Agent Development
Shoemaker, Robert, Ph.D.
robert.shoemaker@nih.gov
240-276-7077
5E454 Co-Chief | Chemopreventive Agent Development
Acting Chief | Nutritional Science
Vlad, Anda, M.D., Ph.D.
anda.vlad@nih.gov
240-276-6422
5E538 Program Officer | Chemopreventive Agent Development

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Valdimarsdottir, Heiddis

Icahn School Of Medicine At Mount Sinai
United States

Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation 5R01CA260961-04 Marjorie Perloff, M.D.
Veiseh, Omid

Rice University
United States

Bioengineered lymphatic regenerating platform for treatment of breast cancer related lymphedema 1R01HL179534-01 Goli Samimi, Ph.D., M.P.H.
Velculescu, Victor E.

Johns Hopkins University
United States

DNA evaluation of fragments for early interception (DELFI) of Lung cancer 5U01CA271896-03 Guillermo Marquez, Ph.D.
Vijayvergia, Namrata

Research Inst Of Fox Chase Can Ctr
United States

Exploring the Neuroprotective Potential of CBD in Preventing Oxaliplatin-Induced Neuropathy: A Prospective Study 1R21CA292276-01A1 Rachel Altshuler, Ph.D.
Villanueva, Augusto

Icahn School Of Medicine At Mount Sinai
United States

Liquid biopsy and radiomics for liver cancer surveillance 4U01CA283931-03 Sidney Fu, M.D.
Vinciguerra, Vincent P

Feinstein Institute For Medical Research
United States

Northwell Health NCORP 3UG1CA189850-11S2 Vanessa A. White, M.P.H.
Wagner, Lynne I.

Ecog-Acrin Medical Research Foundation
United States

ECOG-ACRIN NCORP Research Base 3UG1CA189828-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Wallace, Douglas C

Children'S Hosp Of Philadelphia
United States

Anti-tumor immunity and intestinal microbiota are modulated by mitochondrial DNA 5R01CA259635-04 Young Kim, Ph.D.
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Early detection of colorectal cancer in the traditional and serrated pathways 5R01CA249851-05 Guillermo Marquez, Ph.D.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

Development of a low-cost epigenetic screening assay for Pap specimen-based detection of early-stage ovarian cancer in high-risk women 5R01CA260628-05 Christos Patriotis, Ph.D., M.Sc.
Wang, Kai

Massachusetts General Hospital
United States

Dietary prevention for colorectal cancer: targeting the bile acid/gut microbiome axis 4R00CA283146-03 Amit Kumar, Ph.D.
Wang, Hsiao-Lan

University Of Alabama At Birmingham
United States

A Motion Exergaming Approach to Promote Self-Managing Fatigue and Pain after Head and Neck Cancer Treatment 5R01CA244947-06 Goli Samimi, Ph.D., M.P.H.
Wang, Thomas D

University Of Michigan At Ann Arbor
United States

Peptide multimer for early detection of hepatocellular carcinoma 5R01CA285303-02 Guillermo Marquez, Ph.D.
Wang, Tza-Huei Jeff

Johns Hopkins University
United States

A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies 5R33CA272321-03 Christos Patriotis, Ph.D., M.Sc.
Wang, Linghua

University Of Tx Md Anderson Can Ctr
United States

Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) 4U01CA294518-02 Indu Kohaar, Ph.D., M.Phil., M.Sc.